Open Source Health aims to change the course of Women’s Health with an “At-Home” Hormone Sensor

Investor News

Toronto, Ontario, Canada – December 22, 2014: Open Source Health Inc. (CSE:OSH), a cloud based integrative healthcare platform that puts control into the hands of women to educate, advocate and collaborate on their own healthcare is pleased to announce the development of an advanced “At- Home” device for measuring hormones through a simple finger-prick blood test. The hormone sensor will be priced around $200.00 and each “one-time use” bio-sensor chip will perform up to 5 tests at a cost of $50.00, providing significant cost savings to the healthcare system. This technology supports the trend whereby point of care is shifting from the clinic to the home.

“This sensor would have provided me with critical personal health information and would have changed the course of my life many times over,” states Sonya Satveit, Founder and CEO of Open Source Health Inc. “The standard of care today has women waiting for weeks to receive test results which are only a snapshot of one moment in time. It is crucial for patient-centric healthcare that women are provided with an alternative solution where they can have accurate, affordable and real-time results delivered to their smartphone and put in context of their overall health.”

The hormone sensor uses the latest innovations in nanotechnology, hyper-spectral sensing technology and advanced protein synthesis and has been in development for almost two years. A single drop of blood into the hormone sensor connects to a smartphone and provides immediate results, which are uploaded to the OSH cloud-based platform for analysis by the women’s healthcare team.

“The development of this technology is going to provide the critical day-to-day decision support for integrative health,” stated Dr. Sergey Babichenko, world-renowned Photonics Scientist working with Open Source Health. “With over 200 hormones in the body coordinating our molecular circuitry, it is critical to have a 24/7 view of hormone levels. This area of medical science is not well understood and our efforts will lead to significant breakthroughs for women’s health.”

With a blood sample from a simple finger prick, the single bio-sensing chip will measure steroid hormones such as estrogens, progestogens and androgens. Future plan are underway for enhancing the bio-sensor to include measuring thyroid hormones such as TSH, T3 and T4 along with nutrition and vitamin levels. Each bio-sensor can be used only once and it is anticipated that women will use multiple bio-sensor chips throughout the year making the market for the hormone sensor and bio-sensing chips up to $20 billion USD annually.

Open Source Health has entered in an exclusive joint venture agreement with the option to acquire 100% of the Intellectual Property (“IP”) owned by the joint venture company (“JV”). Patents on this advanced sensing technology will be filed by the JV and will be part of the acquisition; in the meantime OSH has the exclusive rights for commercialization of the IP. Testing of the hormone sensor will commence in 2015 and regulatory approvals for clinical diagnostics will commence in the EU first with FDA Level II approval sought in the USA in mid 2016.

About Open Source Health Inc.:

Open Source Health takes a truly patient-centered approach and is in the business of providing a real-time integrative healthcare solution for women in an open source architecture. Open Source Health Inc. is set to lead the current healthcare revolution by leveraging the latest trends in digital health, personalized health, social health and participatory medicine.

For more information, visit www.opensourcehealth.com

Contact:

For further information, please contact Investor Relations at Open Source Health Inc.
Toll Free: 1.866.403.1933
investor.relations@opensourcehealth.com


Forward Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Open Source Health Inc. (“OSH”), including, but not limited to, the impact of general economic conditions, industry conditions and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

The forward-looking statements contained in this press release are made as of the date of this press release, and OSH does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

Open Source Health Announces Hormone Soup TV Season 1 Designed for Distribution on Digital Channels exceeding 100 million subscribers

Investor News

Toronto, Ontario, Canada – December 12, 2014: Open Source Health Inc. (CSE:OSH), a cloud based integrative healthcare platform that puts control in the hands of women to educate, advocate and collaborate on their own healthcare is pleased to announce that Season 1 of Hormone Soup will begin airing in the second half of 2015. With the Second Screen and digital integration, the shows distribution channels will target daytime TV, over 14 million woman viewers and digital on-demand to over 100 million viewers. Hormone Soup’s content is highly exciting and informative, and will originate users exclusively to the Open Source platform, providing users with access to our full suite of Integrative Health Care services.

“Educating patients is one of the most time-consuming, and therefore most expensive, aspects in delivering quality integrative healthcare.” states Sonya Satveit, CEO and Founder of Open Source Health Inc. “Using digital media such as video and second screen technology we can provide an enhanced and interactive educational experience that brings tremendous awareness to the Open Source Health Platform – we are very pleased that this strategic alliance will drive our growth and open up new avenues to better health for patients and customers”

Season 1 will have 30 episodes centred around women’s hormone, reproductive and sexual health. Television show topics will focus on women’s health issues that have either a high prevalence, are poorly understood, or are controversial, such as:

  1. Thyroid Disorder: 200 million worldwide
  2. Infertility: 15% of couples
  3. Mental health – often linked to endocrine disorders
  4. Polycystic Ovarian Syndrome (PCOS) – 1 in 10 women worldwide
  5. Endometriosis: 176 million women worldwide, commonly misdiagnosed
  6. Miscarriage: 10 – 25% of all pregnancies end in miscarriage
  7. Dense Breast Tissue: over 40% of women
  8. Perinatal Mood Disorder: 15 – 20% of new mothers
  9. Ovarian Cancer: Quarter of a million women diagnosed each year
  10. Endometrial Cancer: over 300,000 women diagnosed each year
  11. Uterine Fibroids: 235 million women suffer worldwide
  12. Perimenopause: 100’s of millions of women
  13. Menopause: 100’s of millions of women
  14. Hysterectomy: 1 in 3 women in the USA will have a hysterectomy by age 60
  15. Pre-Menstrual Syndrome (PMS): 48% of women worldwide
  16. Pre-Menstrual Dysphoric Disorder (PMDD): between 3 – 8% of women worldwide

Each episode will feature the host, Sonya Satveit, interviewing leading physicians and health professionals, as well as patients that have suffered and are now managing their health through integrative medicine approaches. The goal of each show is to educate and provide women with key strategies around advocating for themselves to help them live a healthy and abundant life. With the explosion in digital health, each episode will also include a technology update featuring the latest innovations in women’s health.

Show production will commence in the first half of 2015 with release to be scheduled after Sept 2015.

About Hormone Soup Inc:

Hormone Soup (www.hormonsoup.com) is a women’s hormone health website where Founder and President, Sonya Satveit publishes her story and research. As a empowered patient and women’s health advocate her story has touched women in over 100 countries. These women and their similar health struggles helped inspire the creation of the Integrative Healthcare platform within Open Source Health. Sonya continues to publish her stories with the hope that this information may make a difference in women’s day-to-day lives.

About Open Source Health Inc.:

Open Source Health takes a truly patient-centered approach and is in the business of providing a real-time integrative healthcare solution for women in an open source architecture. Open Source Health Inc. is set to lead the current healthcare revolution by leveraging the latest trends in digital health, personalized health, social health and participatory medicine.

For more information, visit www.opensourcehealth.com

Contact:

For further information, please contact Investor Relations at Open Source Health Inc.
Toll Free: 1.866.403.1933
investor.relations@opensourcehealth.com


Forward Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Open Source Health Inc. (“OSH”), including, but not limited to, the impact of general economic conditions, industry conditions and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

The forward-looking statements contained in this press release are made as of the date of this press release, and OSH does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

Open Source Health Announces openEMR Collaboration with more then 50,000 annual downloads to Clinics in 200 Countries

Investor News

Toronto, Ontario, Canada – December 11, 2014: Open Source Health Inc. (CSE:OSH), a cloud based integrative healthcare platform that puts control in the hands of women to educate, advocate and collaborate on their own healthcare is pleased to announce it has entered into an agreement with Medical Information Integration LLC, of Portland, Oregon, USA to add Open Source Health’s technology for Integrative and Preventive medicine to their advanced openEMR platform making it the first of its kind globally. This will allow the thousands of clinics and practitioners serving millions of patients in over 200 countries to expand their practice from disease management to Integrative and Preventive Medicine.

“One of the barriers holding back the acceleration of integrative and preventive medicine is the Electronic Health Record platforms available in the USA and around the world”, states Sonya Satveit, Founder and CEO of Open Source Health Inc. “Empowered Patients that want to take control of their health through an integrative and preventive approach yet have no systems support, this is holding back the adoption”.

The EMR platform (known as the Electronic Medical Record or Electronic Health Record) is used to manage the patient’s health record and provide medical practice management including back office functions such as insurance billing, provider calendar and prescription issuance. The USA, India Indonesia, Kenya and Mexico represent the top five countries utilizing the openEMR platform. OSH is offering it’s base functionality for integrative and preventive health to the open source community allowing the global dissemination to over 200 counties. Then, OSH will offer the thousands of practitioners and clinics the option to add OSH’s proprietary Artificial & Learning technology, which acts a plugin to the openEMR platform, dramatically reducing the clinic’s operating costs and increasing revenues as they expand their healthcare programs. OSH will charge a fee to the provider’s for the use of the OSH proprietary technology as healthcare is delivered over the cloud.

The current openEMR platform will provide the base starting point for development and includes the following functionality today:

  • Patient Demographics
  • Patient Scheduling
  • Electronic Medical Record
  • Prescriptions
  • Labs requisitions and results storage
  • Medical billing
  • Clinical Decision Rules
  • Patient Portal
  • Reports
  • Multilanguage support, (over 20 languages supported to date)

About the OpenEMR Initiative

OpenEMR is a Free and Open Source electronic health records and medical practice management application that can run on Windows, Linux, Mac OS X, and many other platforms. OpenEMR is ONC Complete Ambulatory EHR certified and is one of the most popular open source electronic medical records in use today with over 4,000 downloads monthly. OpenEMR is supported by a strong community of volunteers and professionals all with the common goal of making OpenEMR a superior alternative to its proprietary counterparts. The OpenEMR community and the OEMR.org 501(c)3 is dedicated to guarding OpenEMR's status as a free, open source software solution for medical practices and is dedicated to maintaining a spirit of openness, kindness and cooperation.

For more information visit: www.open-emr.org

Statistics on openEMR usage: openEMR

Product Demo: www.mi-squared.com

About Medical Information Integration, LLC (“MI-Squared”)

MI-Squared has decades of experience in medical & practice management, and the design and implementation of medical informatics. MI-Squared is proud of its active contribution to the OpenEMR project. MI2 has resources and a successful track record enabling providers to deliver better care to patients, more cost effectively. The founder and CEO, Tony McCormick, has been involved in HealthCare IT since 1988 where he was part of a team that had started one of the first Preferred Provider Organizations in Texas. Later he developed applications for the HMO market, Independent Practitioners Medical Records and Billing systems and large clinical systems. In Oregon he was a lead analyst on the Oregon Medical Electronic Network which was run by the Oregon Medical Association. He founded MI-Squared with the desire to help reduce the high cost of medical services by providing efficient, easy to use software based on the Free Open Source Software model.

For more information: www.mi-squared.com

About Open Source Health Inc.:

Open Source Health takes a truly patient-centered approach and is in the business of providing a real-time integrative healthcare solution for women in an open source architecture. Open Source Health Inc. is set to lead the current healthcare revolution by leveraging the latest trends in digital health, personalized health, social health and participatory medicine.

For more information, visit www.opensourcehealth.com

Contact:

For further information, please contact Investor Relations at Open Source Health Inc.
Toll Free: 1.866.403.1933
investor.relations@opensourcehealth.com


Forward Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Open Source Health Inc. (“OSH”), including, but not limited to, the impact of general economic conditions, industry conditions and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

The forward-looking statements contained in this press release are made as of the date of this press release, and OSH does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

Open Source Health Announces Collaboration Agreement with Geneyouin Inc., – Personalized Medicine and Genomics

Investor News

Toronto, Ontario, Canada – December 9, 2014: Open Source Health Inc. (CSE:OSH) (“OSH”/Company”), a cloud based integrative healthcare platform that puts control in the hands of women to educate, advocate and collaborate on their own healthcare is pleased to announce it has entered into a Memorandum of Understanding with Geneyouin Inc., a leading company in Genomic research for personalized medicine to collaborate on the commercialization of OSH’s cloud based platform for integrated and preventive healthcare.

“Using genome sequencing technology provides insight for your integrative health care team when creating a personalized integrative and preventive health care plan.”, states Sonya Satveit, Founder and CEO of Open Source Health Inc. “There are many genetic tests already developed that help with early diagnosis for the development of a personalized program, especially with women’s health. This genetic information will be part of the Patient Record and will allow the health care team to develop targeted preventive healthcare to improve wellness and reduce medical costs”.

It is known that the human body contains about 20 trillion living cells with each cell containing about 23,000 genes. This collection of genes is known as the genome and contains the instructions for sustaining a human being. Mutations in the genome increase disease susceptibility and initiate such diseases as cancer, autoimmune diseases, infertility, and mental health for example.

With the methods developed by Geneyouin, a greater understanding of the each person’s individual genome will allow scientists and clinicians to develop personalized medicine. From the individual’s genome such benefits of disease prediction, prevention and treatment will be tailored individually to each patients unique genome. The Patients Integrative Healthcare team will be able to assess the person’s risks to diseases, sensitivities to drugs, and overall wellness and prescribe an individualized continual care and wellness program. This revolution in personalized medicine, which Open Source is on the leading edge of advancing, will lead to healthier lives and lower health care costs. According to a recent study by PriceWaterhouseCoopers, personalized medicine is already a $286 billion industry in the United States.

“Significant breakthroughs in genomic research and its application to personalized medicine are already showing dramatic benefits to healthcare today, especially as it relates to women’s health”, states Dr. Ruslan Dorfman, CEO and Founder of Genyouin Inc., a Toronto, Canada based company. “At Geneyouin we are developing the disease diagnostic automation to focus on obtaining certain genetic knowledge making this affordable and efficient. We have already developed several tools including PillCheckTM for personalized drug response annotation, and Genealogy for annotating health risks based on family history of disease”

OSH is collaborating with Geneyouin on the definition and design of the next generation Electronic Health Record (“EHR”) for integrative and preventive medicine and by incorporating each patients genome into their record, the healthcare team can tailor individual care program to improve wellness and practice prevention. In a 2009 report issued by the National Center for Disease Control and Prevention it stated of the top 6 chronic diseases that consume 78% of the total healthcare spending in the USA, if an individual were to practice prevention, healthcare costs would drop by 58%. Here are some supporting statistics from the report:

  • 7 out of 10 deaths among Americans are from chronic diseases
  • In 2005, 1 out of 2 Americans had at least 1 chronic disease
  • Top Chronic Diseases: Heart Disease, Cancer, Diabetes, Arthritis, Obesity, Respiratory Disease and Oral Conditions
  • Main Cause: Lack of Physical Activity, Poor Nutrition, Tobacco Use, Excessive Alcohol Consumption, Stress
  • Chronic diseases can be reduced by at least 50% if prevention is practiced dramatically reducing cost of healthcare.

The EHR of the future will support and provide the evidence through genomic discovery of personalized medicine and develop a complete integrated and preventive program. Empowering the Patient first with knowledge, then with an advocacy model along with the collaborative tools to assist in their path to wellness defines the next generation EHR. OSH’s cloud based platform that has the potential to become the cornerstone of Integrative and Preventive Health will be created from the Company’s collaboration between a number of the top global digital health companies and renowned healthcare practitioners and experts.

About Geneyouin Inc.

GeneYouIn provides genetic testing and consulting services to Executive, Fertility and other specialty clinics, as well as to individuals.  GeneYouIn’s products aim to inform clients, and their healthcare providers, about genetic variations that may affect drug response and inherited disease risks, to help optimize health management. To provide unique insights on an individuals health, GeneYouIn developed innovative software solutions for pharmacogenetic genome annotation available for clinical diagnostic laboratories. A genetic test from GeneYouIn provides invaluable, actionable information about an individual’s genetic make-up enabling to take targeted, pro-active steps towards a healthy and active life.

For more information visit: www.geneyouin.ca

About Open Source Health Inc.:

Open Source Health takes a truly patient-centered approach and is in the business of providing a real-time integrative healthcare solution for women in an open source architecture. Open Source Health Inc. is set to lead the current healthcare revolution by leveraging the latest trends in digital health, personalized health, social health and participatory medicine.

For more information, visit www.opensourcehealth.com

Contact:

For further information, please contact Investor Relations at Open Source Health Inc.
Toll Free: 1.866.403.1933

investor.relations@opensourcehealth.com


Forward Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Open Source Health Inc. (“OSH”), including, but not limited to, the impact of general economic conditions, industry conditions and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

The forward-looking statements contained in this press release are made as of the date of this press release, and OSH does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.